- Home
- SHOO vs LIVN Comparison
SHOO vs LIVN Comparison
Compare SHOO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOO
- LIVN
- Stock Information
- Founded
- SHOO 1990
- LIVN 1987
- Country
- SHOO United States
- LIVN United Kingdom
- Employees
- SHOO N/A
- LIVN N/A
- Industry
- SHOO Shoe Manufacturing
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SHOO Consumer Discretionary
- LIVN Health Care
- Exchange
- SHOO Nasdaq
- LIVN Nasdaq
- Market Cap
- SHOO 3.0B
- LIVN 2.6B
- IPO Year
- SHOO 1993
- LIVN 1993
- Fundamental
- Price
- SHOO $38.23
- LIVN $47.44
- Analyst Decision
- SHOO Hold
- LIVN Buy
- Analyst Count
- SHOO 6
- LIVN 7
- Target Price
- SHOO $43.80
- LIVN $67.14
- AVG Volume (30 Days)
- SHOO 727.3K
- LIVN 447.2K
- Earning Date
- SHOO 02-26-2025
- LIVN 02-25-2025
- Dividend Yield
- SHOO 2.19%
- LIVN N/A
- EPS Growth
- SHOO 6.16
- LIVN 759.09
- EPS
- SHOO 2.36
- LIVN 0.43
- Revenue
- SHOO $2,220,323,000.00
- LIVN $1,241,739,000.00
- Revenue This Year
- SHOO $15.82
- LIVN $10.18
- Revenue Next Year
- SHOO $5.01
- LIVN $5.43
- P/E Ratio
- SHOO $16.42
- LIVN $110.76
- Revenue Growth
- SHOO 14.89
- LIVN 11.04
- 52 Week Low
- SHOO $36.40
- LIVN $43.15
- 52 Week High
- SHOO $50.01
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- SHOO 39.89
- LIVN 44.11
- Support Level
- SHOO $37.29
- LIVN $46.75
- Resistance Level
- SHOO $40.02
- LIVN $49.96
- Average True Range (ATR)
- SHOO 1.00
- LIVN 1.24
- MACD
- SHOO 0.13
- LIVN -0.09
- Stochastic Oscillator
- SHOO 50.55
- LIVN 21.50
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.